Literature DB >> 1569393

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes.

A Franco1, M Paroli, U Testa, R Benvenuto, C Peschle, F Balsano, V Barnaba.   

Abstract

Human activated T lymphocytes expressing class II molecules are able to present only complex antigens that bind to their own surface receptors, and thus can be captured, internalized, and processed through the class II major histocompatibility complex processing pathway. We have used the antigen-presenting T cell system to identify the viral receptor used by hepatitis B virus (HBV) to enter cells, as well as the sequence of HB envelope antigen (HBenvAg) involved in this interaction. Results show that both CD4+ and CD8+ T clones can process and present HBenvAg to class II-restricted cytotoxic T lymphocytes and that the CD71 transferrin receptor (TfR) is involved in efficient HBenvAg uptake by T cells. Moreover, we provide evidence that the HBenvAg sequence interacting with the T cell surface is contained within the pre-S2 region. Since TfR is also expressed on hepatocytes, it might represent a portal of cellular entry for HBV infection. This system of antigen presentation by T cells may serve as a model to study both lymphocyte receptors used by lymphocytotropic viruses and viral proteins critical to bind them.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569393      PMCID: PMC2119224          DOI: 10.1084/jem.175.5.1195

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

Review 1.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  The cell biology of antigen processing and presentation.

Authors:  F M Brodsky; L E Guagliardi
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 3.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  Presentation of autoantigen by human T cells.

Authors:  J M LaSalle; K Ota; D A Hafler
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

5.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor.

Authors:  R A Ezekowitz; D J Williams; H Koziel; M Y Armstrong; A Warner; F F Richards; R M Rose
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

6.  Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells.

Authors:  H Körner; A Schliephake; J Winter; F Zimprich; H Lassmann; J Sedgwick; S Siddell; H Wege
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

7.  Is the acetylcholine receptor a rabies virus receptor?

Authors:  T L Lentz; T G Burrage; A L Smith; J Crick; G H Tignor
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

8.  Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.

Authors:  H K Ziegler; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Hepatitis B virus infection in cultured human lymphoblastoid cells.

Authors:  J L Romet-Lemonne; M F McLane; E Elfassi; W A Haseltine; J Azocar; M Essex
Journal:  Science       Date:  1983-08-12       Impact factor: 47.728

10.  Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.

Authors:  T H Ottenhoff; T Mutis
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 3.  Involvement of CD80 in the generation of CD4+ cytotoxic T cells.

Authors:  D Mauri; W J Pichler
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

6.  Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

Authors:  R Schirmbeck; K Melber; T Mertens; J Reimann
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

8.  The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway.

Authors:  E Lara-Pezzi; A L Armesilla; P L Majano; J M Redondo; M López-Cabrera
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.

Authors:  Daniele Accapezzato; Vittorio Francavilla; Marino Paroli; Marco Casciaro; Lucia Valeria Chircu; Agostino Cividini; Sergio Abrignani; Mario U Mondelli; Vincenzo Barnaba
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 10.  Hepatitis B virus immunopathology.

Authors:  F V Chisari; C Ferrari
Journal:  Springer Semin Immunopathol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.